30.09.2022 Vitruvia Medical AG  CH0461931419

EQS-News: Vitruvia Medical AG: Successful certification of FFP 2 masks with medical approval of LT technologies


 

EQS-News: Vitruvia Medical AG / Key word(s): Product Launch/Market Launch
Vitruvia Medical AG: Successful certification of FFP 2 masks with medical approval of LT technologies

30.09.2022 / 09:52 CET/CEST
The issuer is solely responsible for the content of this announcement.


 

   

 

Successful certification of FFP 2 masks with medical approval

of LT technologies

 

 

LT technologies has successfully passed the certification of the FFP2 masks with medical approval.

The TechMed Mask is a particle-filtering half mask for protection against aerosols, including viruses and particles. It is excellent for use in infection control and protects the wearer and those around them.

As LT technologies maintains a certified quality management system in accordance with the DIN EN ISO 13485:2016 standard, the respiratory protection mask was also certified in accordance with type IIR DIN/EN 14683:2016-10 in addition to TÜV Rheinland in accordance with DIN/EN 149:2001+A1:2009. This makes us one of the few manufacturers worldwide to produce masks with this double certification.

 

This FFP2 mask gives LT technologies a unique selling point. To date, there is no tm mask on the German market. The company is thus able to establish itself uniquely in Germany with its application in the medical sector and is optimally prepared for the next Corona wave. We assume that this aspect will become even more important. Supply bottlenecks from Asia have shown that European production is increasingly being used, if it is available.

LT technologies has already received the first orders. The FFP2 mask with medical approval will mainly be for hospital use, but the end user will probably also prefer this medical protection. From October 2022, we will produce the masks in-house "Made in Germany".

Further information about LT technologies GmbH &Co KG can be found on the home page : www.lt-technologies.de

 

About Vitruvia Medical AG :

Vitruvia Medical AG is a Swiss holding company with a focus on repair, production and trade of medical devices as well as surgical instruments.

Vitruvia thus combines innovative and sustainable solutions for medical-technical progress, customer benefit and economic success.

 

 

 



30.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Vitruvia Medical AG
Kesselackerstr. 18
5611 Anglikon
Switzerland
Phone: +41 44 915 33 78
E-mail: [email protected]
Internet: www.vitruvia-med.com
ISIN: CH0461931419
WKN: A2PDWF
Listed: Regulated Unofficial Market in Munich
EQS News ID: 1453815

 
End of News EQS News Service

1453815  30.09.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1453815&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 0,00 0,00 0,00 5,60 1,97 1,42 0,00
EBITDA1,2 0,00 0,00 0,00 -0,96 -0,75 -0,91 0,00
EBITDA-Marge3 0,00 0,00 0,00 -17,14 -38,07 -64,08
EBIT1,4 0,00 0,00 0,00 -1,31 -7,69 -1,24 0,00
EBIT-Marge5 0,00 0,00 0,00 -23,39 -390,36 -87,32 0,00
Jahresüberschuss1 0,00 0,00 0,00 -1,54 -7,71 -1,48 0,00
Netto-Marge6 0,00 0,00 0,00 -27,50 -391,37 -104,23 0,00
Cashflow1,7 0,00 0,00 0,00 -0,21 -0,78 -0,67 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 -0,85 -4,19 -0,59 -0,15
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Vitruvia Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2PDWF 0,400 1,00
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 -0,16
KBV KCV KUV EV/EBITDA
-0,51 - 0,71 -1,08
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 26.07.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.09.2023 26.06.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-38,37% -52,04% -66,67% -80,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Vitruvia Medical AG  ISIN: CH0461931419 können Sie bei EQS abrufen


Medtech , A2PDWF , 991 , MUN:991